The three founders Richard Fobo, Johannes Ruopp and Kerstin von Diemar were concerned about the often inaccurate and inadequate care of over 12 million people with chronic wounds worldwide. That's why they joined forces and in 2021 founded cureVision, the first 3D wound analysis system approved by the European Medical Device Regulation (MDR).
As a result, it was awarded the German "Startup and Digitalization Award" by the Entscheiderfabrik in 2023, won 2nd place at the Digital Health Award 2023, and was recently accepted into the "WomanTechEU" program, receiving grants of 75,000 euros, as well as mentoring, coaching, and special networking opportunities from the European Innovation Council (EIC).
cureVision CEO Kerstin von Diemar comments:
"We are very proud to have been selected for the grant. This spurs us on to further advance the use of artificial intelligence in medicine and especially in the care of chronic wounds. Personally, I think it's fantastic that almost half of the German deeptech startups in the program are from Munich. It's a great validation of the intense work of everyone involved in the Munich tech startup ecosystem, and we as Curevision have a lot to thank them for."
It remains to wish the SCE alumni startup much success in its ambitious goal of using the built-in artificial intelligence in their product to optimize wound care in a personalized way for each of their patient.
For more information, also see this article from Munich Startup.
More info on cureVision.